Target intelligence / Profile preview

n-Dodecyl-beta-D-maltoside (DDM)

Target
DDM
Molecular classification
Non-ionic detergent, Alkyl glycoside, Surfactant
01

Overview

n-Dodecyl-beta-D-maltoside (DDM) is a non-ionic detergent primarily used as a biochemical reagent to solubilize and stabilize integral membrane proteins from cellular lipid bilayers (PubChem CID 5361444). It is widely regarded as a gold standard in structural biology for maintaining the native conformation and activity of proteins like G protein-coupled receptors (GPCRs) during purification and crystallization (Anatrace, 2023). DDM functions by inserting its hydrophobic dodecyl chain into the lipid bilayer, eventually disrupting the membrane to form protein-detergent micelles. While it is essential for the study of membrane-associated drug targets, DDM itself is not a therapeutic target, receptor, or enzyme involved in disease pathways. Its use is restricted to in vitro laboratory settings, as its ability to dissolve lipid bilayers makes it cytotoxic to living cells at concentrations above its critical micelle concentration (CMC). Consequently, it does not have a role in disease pathology or as a site for drug action in a clinical sense.

Other names
Lauryl maltosideDodecyl maltosiden-Dodecyl-beta-D-maltopyranosideDDMDodecyl-beta-D-maltoside
02

Mechanism of action

Solubilization of lipid bilayers through the formation of mixed micelles, preserving the native conformation of integral membrane proteins.

03

Biological functions

Membrane protein solubilizationProtein stabilizationMicelle formation
04

Safety considerations

Membrane disruptionCytotoxicity in live cell assaysInterference with certain biochemical assays

Beyond the preview

Go deeper on n-Dodecyl-beta-D-maltoside (DDM).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on n-Dodecyl-beta-D-maltoside (DDM).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call